![John Paul de Koning](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Paul de Koning
Directeur/Membre du Conseil chez
ONWARD MEDICAL N.V.
Profil
John Paul de Koning is Director at eTheRNA immunotherapies NV, ONWARD Medical SA, Xylocor Therapeutics, Inc., Aelin Therapeutics NV, Xilis, Inc., and Visus Therapeutics, Inc. He is Non-Executive Director at GTX medical BV.
He serves on the Supervisory Board of Coöperatief LSP IV UA and VarmX BV.
He is Partner at EQT Life Sciences Group BV.
Former roles include Non-Executive Director at Innovative Biosensors, Inc. and argenx SE, Director at Prosensa Holding NV, Director-Supervisory Board at Skyline Diagnostics BV, Independent Non-Executive Director at Merus NV, Managing Director at Semaia Pharmaceuticals, Member-Supervisory Board at BMEYE BV, and Non-Executive Member-Supervisory Board at MyCartis NV.
Education includes a doctorate from Erasmus University Rotterdam and graduate studies at the University of Utrecht.
Postes actifs de John Paul de Koning
| Sociétés | Poste | Début |
|---|---|---|
| ONWARD MEDICAL N.V. | Directeur/Membre du Conseil | 01/01/2016 |
LSP Management Group BV
 LSP Management Group BV Investment ManagersFinance EQT Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, medical devices, diagnostics and healthtech sectors. It provides financing for early and later stage capital requirements with an investment size of EUR 10 – 60 million. | Private Equity Investor | 06/06/2006 |
eTheRNA immunotherapies NV
 eTheRNA immunotherapies NV BiotechnologyHealth Technology Operates as a technology platform that develops mRNA and lipid nanoparticle therapeutics | Directeur/Membre du Conseil | 01/03/2016 |
Visus Therapeutics, Inc.
 Visus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops ophthalmic therapeutic medicines | Directeur/Membre du Conseil | 01/01/2021 |
Varmx BV
 Varmx BV BiotechnologyHealth Technology Develops and manufactures therapeutic proteins to restore hemostasis | Directeur/Membre du Conseil | 01/01/2020 |
Xylocor Therapeutics, Inc.
 Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel gene therapy for cardiovascular disease | Directeur/Membre du Conseil | - |
Aelin Therapeutics NV
 Aelin Therapeutics NV Pharmaceuticals: MajorHealth Technology Develops drugs for antibiotics and first-in-class therapeutics | Directeur/Membre du Conseil | - |
Onward Medical SA
 Onward Medical SA BiotechnologyHealth Technology Develops novel therapies for improved rehabilitation of patients suffering from spinal-cord injuries | Directeur/Membre du Conseil | 01/01/2016 |
Coöperatief LSP IV UA
 Coöperatief LSP IV UA Investment ManagersFinance Acts as Venture Capital Fund | Directeur/Membre du Conseil | 01/01/2010 |
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de John Paul de Koning
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de John Paul de Koning
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
74
Relations au 1er degré
20
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 20 |
|---|---|
Innovative Biosensors, Inc.
 Innovative Biosensors, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets pathogen detection and diagnostic systems | Health Technology |
BMEYE BV
 BMEYE BV Electronic Equipment/InstrumentsElectronic Technology Manufactures and distributes non-invasive technology, hemodynamic monitoring equipment and related medical devices | Electronic Technology |
Coöperatief LSP IV UA
Coöperatief LSP IV UA Investment ManagersFinance Acts as Venture Capital Fund | Finance |
LSP Management Group BV
LSP Management Group BV Investment ManagersFinance EQT Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, medical devices, diagnostics and healthtech sectors. It provides financing for early and later stage capital requirements with an investment size of EUR 10 – 60 million. | Finance |
Erasmus University Rotterdam
 Erasmus University Rotterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Utrecht
 University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MyCartis NV
 MyCartis NV BiotechnologyHealth Technology Develops technologies for healthcare personalization needs | Health Technology |
Prosensa Holding NV
 Prosensa Holding NV BiotechnologyHealth Technology Engages in the development of ribonucleic acid-modulating or RNA-modulating, therapeutics for the treatment of genetic disorders | Health Technology |
Skyline Diagnostics BV
 Skyline Diagnostics BV Electronic Equipment/InstrumentsElectronic Technology Develops and commercializes diagnostic tools | Electronic Technology |
Merus NV
 Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
argenx SE
 argenx SE BiotechnologyHealth Technology Develops therapies and medicines for the treatment of autoimmune diseases | Health Technology |
Semaia Pharmaceuticals | |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology Operates as a technology platform that develops mRNA and lipid nanoparticle therapeutics | Health Technology |
Onward Medical SA
Onward Medical SA BiotechnologyHealth Technology Develops novel therapies for improved rehabilitation of patients suffering from spinal-cord injuries | Health Technology |
GTX medical BV
 GTX medical BV Medical SpecialtiesHealth Technology Develops novel therapies for improved rehabilitation of patients suffering from spinal-cord injuries | Health Technology |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel gene therapy for cardiovascular disease | Health Technology |
Varmx BV
Varmx BV BiotechnologyHealth Technology Develops and manufactures therapeutic proteins to restore hemostasis | Health Technology |
Aelin Therapeutics NV
Aelin Therapeutics NV Pharmaceuticals: MajorHealth Technology Develops drugs for antibiotics and first-in-class therapeutics | Health Technology |
Xilis, Inc.
 Xilis, Inc. Medical SpecialtiesHealth Technology Develops droplet-based microfluidics technology devices for precision cancer diagnostics and drug development | Health Technology |
Visus Therapeutics, Inc.
Visus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops ophthalmic therapeutic medicines | Health Technology |
